News Picture Generic

Automated Sample Preparation for Content Uniformity Tests of Tablets

February 1, 2016

Pratteln, Switzerland

Develco Pharma Schweiz AG successfully implemented an automated sample preparation system for content uniformity tests of tablets.

Develco’s Managing Director states: “The SWING SP Automated Workstation operates day and night in routine for faster, reliable and robust sample preparation (dispensing of solvents, homogenization and filtration into HPLC vials) of solid dosage forms with retarded release of active pharmaceutical substance.

The SWING SP Automated Workstation allows release of API within a short time (less than ½ hour), whereas traditional sample preparation requires up to 6 hours.

 About Develco Pharma Schweiz AG Develco Pharma operates a laboratory focused on development of solid oral dosage forms. In addition to this, a well-established global network gives the company access to all relevant development and manufacturing technologies.

As a result, Develco Pharma is a reliable outsourcing partner for pharmaceutical marketing organizations. The services offered covers pharmaceutical, analytical and clinical development, registration sourcing and project management The headquarter of Delvelco Pharma is located in Pratteln, Switzerland.

  For additional information please visit www.develco.de

Other Recent News

Discover more news articles you might be interested in

Read more about Identifying critical powder properties for high-throughput dispensing of alumina and organic templates
News Picture 1 1 V2
Jun
16

Identifying critical powder properties for high-throughput dispensing of alumina and organic templates

Screening powder properties such as flowability, compressibility, and particle geometry is crucial for controlling ceramic processing, particularly in automated workflows that demand high reproducibility. Sacrificial templating for porous ceramics is well suited to automation because it is prone to variability arising from manual handling.

Read more about Integration of Machine Learning and Automated Synthesis for Accelerated Drug and Material Research
News Picture 1 1 V2
Jun
2

Integration of Machine Learning and Automated Synthesis for Accelerated Drug and Material Research

The challenges posed by global climate change and disease risks have intensified the demand for efficient and practical materials and molecules. Traditional trial-and-error approaches are becoming increasingly inefficient and resource-intensive. The rapid advancement of artificial intelligence (AI) has opened new avenues to accelerate research and shorten development cycles.

© Chemspeed Technologies 2026